Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $5.0900 (-3.05%) ($4.6100 - $5.3900) on Thu. Apr. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 18.59% (three month average) | RSI | 40 | Latest Price | $5.0900(-3.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -4.5% a day on average for past five trading days. | Weekly Trend | SONN declines -37.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) SIL(45%) GDX(32%) IBUY(42%) GDXJ(43%) BOTZ(39%) | Factors Impacting SONN price | SONN will decline at least -9.295% in a week (0% probabilities). UUP(-25%) TIP(-56%) FXI(-32%) CEMB(-44%) MCHI(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -9.295% (StdDev 18.59%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
1 - 5 Day Possible Target | $-53.95(-1159.92%) | Resistance Level | $11.11 | 5 Day Moving Average | $5.27(-3.42%) | 10 Day Moving Average | $7.44(-31.59%) | 20 Day Moving Average | $11.11(-54.19%) | To recent high | -80.8% | To recent low | 0% | Market Cap | $47m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |